IMBRIUM THERAPEUTICS
Imbrium Therapeutics is a biopharma company that specializes in medical science, pharmacologic medicines, and oncology chemotherapeutics.
IMBRIUM THERAPEUTICS
Industry:
Biotechnology Clinical Trials Medical Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Stamford, Connecticut, United States
Country:
United States
Website Url:
http://www.imbriumthera.com
Total Employee:
11+
Status:
Active
Contact:
+1-888-827-0622
Email Addresses:
[email protected]
Similar Organizations
Amitech Therapeutic Solutions
Amitech Therapeutic Solutions specializes in oncology drug research and development.
Aventus Biolabs
Aventus Biolabs is a biotech company that specializes in genetic testing, sampling systems, clinical lab testing, and toxicology solutions.
Cannevert Therapeutics
Cannevert Therapeutics is a biopharma company that deals with the research and practical applications of cannabis in therapeutics.
Elevar Therapeutics
Elevar Therapeutics is a pharmaceutical company that specializes in the development of therapies for unmet medical needs in cancer.
Synterex
Synterex offers clinical solutions to the biotech and pharma industries including publishing, medical writing , and IT collaboration.
UVLrx Therapeutics
UVLrx Therapeutics is a biotechnology company that specializes in the fields of medical, healthcare, and therapeutics.
Official Site Inspections
http://www.imbriumthera.com
- Host name: ec2-35-175-75-201.compute-1.amazonaws.com
- IP address: 35.175.75.201
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Imbrium Therapeutics"
About Us - Imbrium Therapeutics
Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new therapeutics.See details»
Imbrium Therapeutics - Crunchbase Company Profile & Funding
Organization. Imbrium Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone …See details»
Imbrium Therapeutics - LinkedIn
Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics.See details»
Contact Us - Imbrium Therapeutics
© 2024 Imbrium Therapeutics L.P. All Rights Reserved. Imbrium Therapeutics L.P. is a subsidiary of Purdue Pharma L.P.See details»
Imbrium Therapeutics LP - Drug pipelines, Patents, Clinical
For more information, please visit www.imbriumthera.com . References: 1. Zaveri N. The nociceptin opioid receptor (NOP) as a therapeutic target: Progress in translation from …See details»
Imbrium Therapeutics: Contact Details and Business Profile
Imbriumthera.com; pharma.com; 1 914747XXXX; View Similar People. Related Companies Abyrx. 18 $5.2m SpringWorks Therapeutics. 330 Cara Therapeutics. 110 $13m HealthCare Royalty …See details»
Imbrium Therapeutics - Craft
Imbrium Therapeutics is a clinical-stage biopharmaceutical company engaged in the development of pharmacologic and biologic therapeutics. It offers oncology chemotherapeutics, treatments …See details»
Imbrium Therapeutics - Overview, News & Similar companies
Oct 5, 2019 Imbrium Therapeutics contact info: Phone number: (888) 827-0622 Website: www.imbriumthera.com What does Imbrium Therapeutics do? Imbrium is a clinical-stage …See details»
Imbrium Therapeutics - Employees, Contact info, Overview - Wiza
Apr 30, 2024 View info about Imbrium Therapeutics (imbriumthera.com). Imbrium Therapeutics is a company located in Stamford, CT, United States. Find employees, official website, emails, …See details»
Collaboration - Imbrium Therapeutics
Imbrium is dedicated to collaborating with commercial and academic partners to advance novel therapies that address unmet patient need. We welcome the opportunity to learn about new …See details»
Eisai and Imbrium Therapeutics Announce U.S. FDA ... - Eisai Co., Ltd.
Mar 12, 2019 For more information, please visit www.imbriumthera.com. References. 1. Eisai Inc. A multicenter, randomized, double-blind, placebo-conrolled, active comparator, parallel …See details»
Imbrium Therapeutics and TetraGenetics Announce Strategic …
Feb 26, 2019 For Imbrium Therapeutics: [email protected] For TetraGenetics: Suzanne Gibbons-Neff [email protected] 203-858-1325 Release Summary.See details»
Imbrium Therapeutics Announces Enrollment of the First Patient in ...
Mar 5, 2019 Media: U.S. [email protected] Europe and RoW Tiffany Fretwell Communications Lead, Mundipharma [email protected] +44 (0) 1223 393 361See details»
Imbrium Therapeutics Announces Enrollment of the First Patient in ...
STAMFORD, Conn. – March 5, 2019 – Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., in conjunction …See details»
19 Top Pharmaceutical Manufacturers in Connecticut - Inven
Website: imbriumthera.com; Headquarters: Stamford, Connecticut, United States; Founded: 2018; ... TriRx is a CDMO (Contract Development and Manufacturing Organization) that is redefining …See details»
Imbrium Therapeutics L.P. and SpineThera, Inc. Announce First …
Nov 26, 2019 STAMFORD, Conn.--(BUSINESS WIRE)--Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., in …See details»
IMBRIUM THERAPEUTICS L.P. AND SPINETHERA, INC. ANNOUNCE …
Nov 26, 2019 SX600, an investigational non-opioid epidural steroid injection is being evaluated for the treatment of sciatica STAMFORD, Conn. – November 26, 2019 – Imbrium Therapeutics …See details»
Imbrium Therapeutics Announces U.S. FDA Orphan Drug …
Mar 28, 2019 Media: US [email protected] Europe and RoW Tiffany Fretwell Communications Lead, Mundipharma [email protected] Tel: +44 (0) 1223 …See details»
Pipeline - Imbrium Therapeutics
Tinostamustine is a first-in-class, new chemical entity that combines two potentially synergistic mechanisms modes of action, alkylating activity and pan histone deacetylase inhibition (or …See details»